← Leaderboards
Stacy L McAllister
Stanford University
$1,806,105
Attributed
$2,338,174
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2017–25$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,338,174 · 5
By mechanism
R01$1,106,870 · 2
R00$685,750 · 1
R43$292,942 · 1
K99$252,612 · 1
Top collaborators
- Toshihiko Takeuchi1 shared
- Winston E Thompson1 shared
- Luis Villacorta1 shared
Most similar at Stanford University
Same institution · by research overlap
- Jianghong Rao$21,022,312
- David K Stevenson$13,604,013
- Pak H Chan$22,045,925
- Marco Conti$20,166,893
- Eric Sibley$7,139,073
Others in their field
Other Emerging Leaders on “Woman”
- Chanza Baytop · Westat, Inc.$271,217,917
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$29,616,650
- Abraham Aizer Brody · New York University School Of Medicine$16,015,961
- Jeremy James Martinson · University Of Pittsburgh At Pittsburgh$14,031,836
- Michael P Harms · Washington University$13,645,932
- Jorge Eduardo Chavarro · Harvard School Of Public Health$12,830,103
Research focus
WomanEndometriosisPharmaceutical PreparationsEndometrialPainMetabolismProteinsAffectCellsResponseEffective TherapyOperative Surgical ProceduresPathogenesisDetectionAdductAldehydesKnock-InKnock-In MouseMitochondriaExperimental ModelsEnzymesExperimental StudyAldehyde DehydrogenasesBiological Markers
Grant awards (8)
STING inhibition as a therapeutic target for endometriosis$578,397
R01 · FY2025 · HD
Delineating the role of ALDH2 in endometriosis$528,473
R01 · FY2025 · HD · contact PI
Antibody agonist for a G protein-coupled receptor as a treatment for pain in endometriosis$292,942
R43 · FY2022 · HD
Targeting Reactive Aldehyde Metabolism in Endometriosis as a treatment strategy and a Diagnostic Biomarker$237,904
R00 · FY2021 · HD · contact PI
Targeting Reactive Aldehyde Metabolism in Endometriosis as a treatment strategy and a Diagnostic Biomarker$198,846
R00 · FY2020 · HD · contact PI
Targeting Reactive Aldehyde Metabolism in Endometriosis as a treatment strategy and a Diagnostic Biomarker$249,000
R00 · FY2019 · HD · contact PI
Targeting reactive aldehyde metabolism in endometriosis as a treatment strategy and a diagnostic biomarker$126,306
K99 · FY2018 · HD · contact PI
Targeting reactive aldehyde metabolism in endometriosis as a treatment strategy and a diagnostic biomarker$126,306
K99 · FY2017 · HD · contact PI